PDS Biotechnology Corporation has scheduled its 2026 Annual Meeting of Stockholders for August 10, 2026. The company has established a submission deadline of June 25, 2026, for stockholder proposals for inclusion in the proxy materials. PDS Biotechnology is a biotechnology company focused on developing immune-modulating therapies.
